Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Archives of Psychiatry and Clinical Neuroscience
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 6/2006

01.09.2006 | ORIGINAL PAPER

Relationship between insight, cognitive function, social function and symptomatology in schizophrenia

The West London first episode study

verfasst von: Mr. Stanley H. Mutsatsa, Eileen M. Joyce, Sam B. Hutton, Thomas R.E. Barnes

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

To examine the nature and clinical correlates of insight in first-episode schizophrenia, and how these differ from findings in established schizophrenia.

Method

Insight (and insight dimensions), clinical symptoms, neurocognitive function and social function were assessed in 94 patients with first-episode schizophrenia or schizophreniform disorder according to DSM-IV criteria.

Results

Greater global insight was associated with more severe depression. Poor overall insight was associated significantly with more severe negative and disorganisation symptoms as well as poor working memory, and at a trend level with lower current IQ. Patients with poor insight perceived themselves to have a better level of independent performance at daily living activities.

Conclusion

In first-episode psychosis, the clinical correlates of poor insight are similar to those reported for established schizophrenia. Those patients with greater insight may be at risk of depression. The complex relationships between insight, positive and negative symptoms, neurocognitive dysfunction and social function may reflect the multidimensional nature of insight.
Literatur
1.
Schwartz RC (1998) The relationship between insight, illness and treatment outcome in schizophrenia. Psychiatr Q 69:1–22PubMedCrossRef
2.
Ghaemi SN, Pope HG Jr (1994) Lack of insight in psychotic and affective disorders: a review of empirical studies. Harv Rev Psychiatry 2:22–33PubMed
3.
Amador XF, Strauss DH, Yale SA, Gorman JM (1991) Awareness of illness in schizophrenia. Schizophr Bull 17:113–132PubMed
4.
Droulout T, Liraud F, Verdoux H (2003) Relationships between insight and medication adherence in subjects with psychosis. Encephale 29:430–437PubMed
5.
Haberfellner EM, Rittmannsberger H (2004) Weight gain during long-term treatment with olanzapine: a case series. Int Clin Psychopharmacol 19:251–253PubMedCrossRef
6.
Kemp R, David A (1996) Psychological predictors of insight and compliance in psychotic patients. Br J Psychiatry 169:444–450PubMed
7.
Mutsatsa SH, Joyce EM, Hutton SB, Webb E, Gibbins H, Paul S, Barnes TRE (2003) Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatrica Scand 108:439–446CrossRef
8.
Pini S, Cassano GB, Dell’Osso L, Amador XF (2001) Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. Am J Psychiatry 158:122–125PubMedCrossRef
9.
Cuesta MJ, Peralta V (1994) Lack of insight in schizophrenia. Schizophr Bull 20:359–366PubMed
10.
Mintz AR, Dobson KS, Romney DM (2003) Insight in schizophrenia: a meta-analysis. Schizophr Res 61:75–88PubMedCrossRef
11.
Carroll A, Fattah S, Clyde Z, Coffey I, Owens DG, Johnstone EC (1999) Correlates of insight and insight change in schizophrenia. Schizophr Res 35:247–253PubMedCrossRef
12.
McGlashan TH, Carpenter WT Jr (1976) Postpsychotic depression in schizophrenia. Arch Gen Psychiatry 33:231–239PubMed
13.
Smith TE, Hull JW, Santos L (1998) The relationship between symptoms and insight in schizophrenia: a longitudinal perspective. Schizophr Res 33:63–67PubMedCrossRef
14.
Smith TE, Hull JW, Israel LM, Willson DF (2000) Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder. Schizophr Bull 26:193–200PubMed
15.
Amador XF, Friedman JH, Kasapis C, Yale SA, Flaum M, Gorman JM (1996) Suicidal behavior in schizophrenia and its relationship to awareness of illness. Am J Psychiatry 153:1185–1188PubMed
16.
Moore O, Cassidy E, Carr A, O’Callaghan E (1999) Unawareness of illness and its relationship with depression and self-deception in schizophrenia. Eur Psychiatry 14:264–269PubMedCrossRef
17.
Kim CH, Jayathilake K, Meltzer HY (2003) Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophr Res 60:71–80PubMedCrossRef
18.
Schwartz RC (2000) Insight and suicidality in schizophrenia: a replication study. J Nerv Ment Dis 188:235–237PubMedCrossRef
19.
Mohamed S, Fleming S, Penn DL, Spaulding W (1999) Insight in schizophrenia: its relationship to measures of executive functions. J Nerv Ment Dis 187:525–531PubMedCrossRef
20.
Laroi F, Fannemel M, Ronneberg U, Flekkoy K, Opjordsmoen S, Dullerud R, Haakonsen M (2000) Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Res 100:49–58PubMed
21.
Lysaker P, Bell M (1994) Insight and cognitive impairment in schizophrenia. Performance on repeated administrations of the Wisconsin Card Sorting Test. J Nerv Ment Dis 182:656–660PubMedCrossRef
22.
Lysaker PH, Bell MD, Bryson G, Kaplan E (1998) Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function. Acta Psychiatr Scand 97:297–301PubMed
23.
Marks KA, Fastenau PS, Lysaker PH, Bond GR (2000) Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia. Schizophr Res 45:203–211PubMedCrossRef
24.
McEvoy JP, Hartman M, Gottlieb D, Godwin S, Apperson LJ, Wilson W (1996) Common sense, insight, and neuropsychological test performance in schizophrenia patients. Schizophr Bull 22:635–641PubMed
25.
Rossell SL, Coakes J, Shapleske J, Woodruff PW, David AS (2003) Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med 33:111–119PubMedCrossRef
26.
Startup M (1996) Insight and cognitive deficits in schizophrenia: evidence for a curvilinear relationship. Psychol Med 26:1277–1281PubMedCrossRef
27.
Young DA, Zakzanis KK, Bailey C, Davila R, Griese J, Sartory G, Thom A (1998) Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease. J Nerv Ment Dis 186:44–50PubMedCrossRef
28.
Collins AA, Remington GJ, Coulter K, Birkett K (1997) Insight, neurocognitive function and symptom clusters in chronic schizophrenia. Schizophr Res 27:37–44PubMedCrossRef
29.
Sanz M, Constable G, Lopez-Ibor I, Kemp R, David AS (1998) A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med 28:437–446PubMedCrossRef
30.
Goldberg RW, Green-Paden LD, Lehman AF, Gold JM (2001) Correlates of insight in serious mental illness. J Nerv Ment Dis 189:137–145PubMedCrossRef
31.
Barnes TRE, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM (2000) West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br J Psychiatry 177:207–211PubMedCrossRef
32.
McGlashan TH (1999) Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry 46:899–907PubMedCrossRef
33.
Fennig S, Everett E, Bromet EJ, Jandorf L, Fennig SR, Tanenberg-Karant M, Craig TJ (1996) Insight in first-admission psychotic patients. Schizophr Res 22:257–263PubMedCrossRef
34.
Keshavan MS, Rabinowitz J, DeSmedt G, Harvey PD, Schooler N (2004) Correlates of insight in first episode psychosis. Schizophr Res 70:187–194PubMedCrossRef
35.
Koren D, Seidman LJ, Poyurovsky M, Goldsmith M, Viksman P, Zichel S, Klein E (2004) The neuropsychological basis of insight in first-episode schizophrenia: a pilot metacognitive study. Schizophr Res 70:195–202PubMedCrossRef
36.
Mintz AR, Addington J, Addington D (2004) Insight in early psychosis: a 1-year follow-up. Schizophr Res 67:213–217PubMedCrossRef
37.
Thompson KN, McGorry PD, Harrigan SM (2001) Reduced awareness of illness in first-episode psychosis. Compr Psychiatry 42:498–503PubMedCrossRef
38.
David AS (1990) Insight and psychosis. Br J Psychiatry 156:798–808PubMed
39.
Hutton SB, Puri BK, Duncan LJ, Robbins TW, Barnes TRE, Joyce EM (1998) Executive function in first-episode schizophrenia. Psychol Med 28:463–473PubMedCrossRef
40.
Joyce EM, Hutton SB, Mutsatsa S, Gibbins H, Webb E, Paul S, Robbins TW, Barnes TRE (2002) Executive dysfunction in first episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry 181 suppl 43:28–44
41.
Andreasen N (1983) The scale for the assessment of positive symptoms. University of Iowa, Iowa, IA
42.
Andreasen NC (1989) The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl 49–58
43.
Liddle PF, Barnes TRE (1990) Syndromes of chronic schizophrenia. Br J Psychiatry 157:558–561PubMed
44.
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389PubMed
45.
Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S (1990) The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 157:853–859PubMedCrossRef
46.
Nelson H, Willison J (1991) The Revised National Adult Reading Test (NART) test manual, (2nd edn). NFER-Nelson, Windsor
47.
Wechsler D (1981) The Wechsler adult intelligence scale – revised manual. The Psychological Corporation, San Antonio, TX
48.
Sahakian BJ, Owen AM (1992) Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 85:399–402PubMed
49.
Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990) Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 28:1021–1034PubMedCrossRef
50.
Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, Robbins TW (1988) A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson’s disease. Brain 111 Pt 3:695–718PubMed
51.
Shallice T (1982) Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 298:199–209PubMed
52.
Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP, Lange KW, Robbins TW (1992) Fronto-striatal cognitive deficits at different stages of Parkinson’s disease. Brain 115 Pt 6:1727–1751PubMed
53.
Nieuwenstein MR, Aleman A, de Haan EH (2001) Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. J Psychiatr Res 35:119–125PubMedCrossRef
54.
Buckley PF, Hasan S, Friedman L, Cerny C (2001) Insight and schizophrenia. Compr Psychiatry 42:39–41PubMedCrossRef
55.
Debowska G, Grzywa A, Kucharska-Pietura K (1998) Insight in paranoid schizophrenia – its relationship to psychopathology and premorbid adjustment. Compr Psychiatry 39:255–260PubMedCrossRef
56.
Nakano H, Terao T, Iwata N, Hasako R, Nakamura J (2004) Symptomatological and cognitive predictors of insight in chronic schizophrenia. Psychiatry Res 127:65–72PubMedCrossRef
57.
Pallanti S, Quercioli L, Pazzagli A, Rossi A, Dell’Osso L, Pini S, Cassano GB (1999) Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. Am J Psychiatry 156:1094–1096PubMed
58.
Drake RJ, Pickles A, Bentall RP, Kinderman P, Haddock G, Tarrier N, Lewis SW (2004) The evolution of insight, paranoia and depression during early schizophrenia. Psychol Med 34:285–292PubMedCrossRef
59.
Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, Gorman JM (1994) Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 51:826–836PubMed
60.
Weiler MA, Fleisher MH, McArthur-Campbell D (2000) Insight and symptom change in schizophrenia and other disorders. Schizophr Res 45:29–36PubMedCrossRef
61.
Alloy, LB, Abramson LY (1998) Depressive realism: four theoretical perspectives. In: Alloy LB (ed) Cognitive processes in depression, Guilford, New York, pp 223–265
62.
Taylor SE, Brown JD (1988) Illusion and well-being: a social psychological perespective on mental health. Psychiatr Bull 103:193–210CrossRef
63.
Liddle PF, Barnes TR, Curson DA, Patel M (1993) Depression and the experience of psychological deficits in schizophrenia. Acta Psychiatr Scand 88:243–247PubMed
64.
Michalakeas A, Skoutas C, Charalambous A, Peristeris A, Marinos V, Keramari E, Theologou A (1994) Insight in schizophrenia and mood disorders and its relation to psychopathology. Acta Psychiatr Scand 90:46–49PubMed
65.
David AS (1999) “To see ourselves as others see us”. Aubrey Lewis’s insight. Br J Psychiatry 175:210–216PubMedCrossRef
66.
Peralta V, Cuesta MJ (1994) Lack of insight: its status within schizophrenic psychopathology. Biol Psychiatry 36: 559–561PubMedCrossRef
67.
Drake RJ, Lewis SW (2003) Insight and neurocognition in schizophrenia. Schizophr Res 62:165–173PubMedCrossRef
68.
Pantelis C, Barnes TRE, Nelson HE, Tanner S, Weatherley L, Owen AM, Robbins TW (1997) Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120 Pt 10:1823–1843PubMedCrossRef
69.
Flashman LA, McAllister TW, Johnson SC, Rick JH, Green RL, Saykin AJ (2001) Specific frontal lobe subregions correlated with unawareness of illness in schizophrenia: a preliminary study. J Neuropsychiatry Clin Neurosci 13:255–257PubMed
70.
Dickerson FB, Boronow JJ, Ringel N, Parente F (1997) Lack of insight among outpatients with schizophrenia. Psychiatr Serv 48:195–199PubMed
71.
Mintz AR, Addington J, Addington D (2004) Insight in early psychosis: a 1 year follow up
72.
Drake RJ, Hayley CJ, Akhtar S, Lewis SW (2000) Causes and consequences of duration of untreated psychosis in schizophrenia. Br J of Psychiatry 177:611–615
Metadaten
Titel
Relationship between insight, cognitive function, social function and symptomatology in schizophrenia
The West London first episode study
verfasst von
Mr. Stanley H. Mutsatsa
Eileen M. Joyce
Sam B. Hutton
Thomas R.E. Barnes
Publikationsdatum
01.09.2006
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 6/2006
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-006-0645-7

Weitere Artikel der Ausgabe 6/2006

European Archives of Psychiatry and Clinical Neuroscience 6/2006 Zur Ausgabe

REVIEW

Evidence for beneficial effects of antidepressants on suicidality in depressive patients

ORIGINAL PAPER

Midbrain dopamine D2/3 receptor binding in schizophrenia

ORIGINAL PAPER

Father–infant interaction patterns as precursors of children’s later externalizing behavior problems

ORIGINAL PAPER

The quality of life of the mentally ill living in residential facilities

ORIGINAL PAPER

Cognitive predictors of skill acquisition on social problem solving in patients with schizophrenia

ORIGINAL PAPER

Risperidone augmentation of clozapine

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise